Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases

被引:0
|
作者
Onal, Ugur [1 ,2 ]
Akyol, Deniz [1 ,3 ]
Kaya, Arda [1 ]
Baskol, Dilsah [1 ]
Kenanoglu, Buse [1 ]
Sanlidag, Gamze [1 ]
Onal, Ayse Uyan [1 ,4 ]
Avsar, Cansu Bulut [1 ,5 ]
Mert, Merve [1 ]
Memetali, Seichan [1 ]
Erdem, Hueseyin Aytac [1 ]
Bozkurt, Devrim [6 ]
Simsir, Adnan [7 ]
Bozbiyik, Osman [8 ]
Kahraman, Umit [9 ]
Ozgiray, Erkin [10 ]
Korkmaz, Pervin [11 ]
Cilli, Feriha [12 ]
Pullukcu, Husnu [1 ]
Yamazhan, Tansu [1 ]
Tasbakan, Meltem Isikgoz [1 ]
Arda, Bilgin [1 ]
Ulusoy, Sercan [1 ]
Sipahi, Oguz Resat [1 ,13 ]
机构
[1] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkiye
[2] Uludag Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Bursa, Turkiye
[3] Kagizman State Hosp, Infect Dis Clin, Kars, Turkiye
[4] Yuksek Ihtisas Teaching & Res Hosp, Dept Urol, Bursa, Turkiye
[5] Bakircay Univ, Cigli Teaching & Res Hosp, Izmir, Turkiye
[6] Ege Univ, Fac Med, Dept Internal Med, Izmir, Turkiye
[7] Ege Univ, Fac Med, Dept Urol, Izmir, Turkiye
[8] Ege Univ, Fac Med, Dept Gen Surg, Izmir, Turkiye
[9] Ege Univ, Fac Med, Dept Cardiovasc Surg, Izmir, Turkiye
[10] Ege Univ, Fac Med, Dept Neurosurg, Izmir, Turkiye
[11] Ege Univ, Fac Med, Dept Chest Dis, Izmir, Turkiye
[12] Ege Univ, Fac Med, Dept Med Microbiol, Izmir, Turkiye
[13] King Hamad Univ Hosp, Bahrain Oncol Ctr, Infect Dis Dept, Muharraq, Bahrain
关键词
Double carbapenem therapy; Carbapenem-resistant Klebsiella pneumonia; Bacteremia; THERAPY; INFECTIONS;
D O I
10.1007/s10096-023-04660-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Herein, we aimed to describe the outcomes of patients with blood stream infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) who received ertapenem plus meropenem combination treatment (EMCT). A total of 53 patients with culture proven CR-Kp bacteremia treated with ertapenem + meropenem were included. The patients with secondary bacteremia due to urinary tract infection exhibited a significantly lower 1-month mortality (OMM), particularly in those with microbiological eradication and those with end-of-treatment success. Salvage EMCT resulted in 49% 1-month survival.
引用
收藏
页码:1269 / 1273
页数:5
相关论文
共 50 条
  • [1] Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases
    Uğur Önal
    Deniz Akyol
    Arda Kaya
    Dilşah Başkol
    Buse Kenanoglu
    Gamze Şanlıdağ
    Ayşe Uyan Önal
    Cansu Bulut Avşar
    Merve Mert
    Seichan Memetali
    Hüseyin Aytaç Erdem
    Devrim Bozkurt
    Adnan Şimşir
    Osman Bozbıyık
    Ümit Kahraman
    Erkin Özgiray
    Pervin Korkmaz
    Feriha Çilli
    Hüsnü Pullukçu
    Tansu Yamazhan
    Meltem Işıkgöz Taşbakan
    Bilgin Arda
    Sercan Ulusoy
    Oğuz Reşat Sipahi
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 1269 - 1273
  • [2] Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae
    Shields, Ryan K.
    Clancy, Cornelius J.
    Press, Ellen G.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3187 - 3192
  • [3] In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae
    Elif Odabaş Köse
    Folia Microbiologica, 2022, 67 : 143 - 156
  • [4] In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae
    Kose, Elif Odabas
    FOLIA MICROBIOLOGICA, 2022, 67 (01) : 143 - 156
  • [5] Proteomic analysis of a carbapenem-resistant Klebsiella pneumoniae strain in response to meropenem stress
    Khan, Arbab
    Sharma, Divakar
    Faheem, Mohammad
    Bisht, Deepa
    Khan, Asad U.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 8 : 172 - 178
  • [6] Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy
    Lee, Nan-Yao
    Tsai, Chin-Shiang
    Syue, Ling-Shan
    Chen, Po-Lin
    Li, Chia-Wen
    Li, Ming-Chi
    Ko, Wen-Chien
    CLINICAL THERAPEUTICS, 2020, 42 (03) : E33 - E44
  • [7] Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
    Borer, Abraham
    Saidel-Odes, Lisa
    Riesenberg, Klaris
    Eskira, Seada
    Peled, Nejama
    Nativ, Ronit
    Schlaeffer, Francisc
    Sherf, Michael
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (10): : 972 - 976
  • [8] Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
    Gomez-Simmonds, A.
    Nelson, B.
    Eiras, D. P.
    Loo, A.
    Jenkins, S. G.
    Whittier, S.
    Calfee, D. P.
    Satlin, M. J.
    Kubin, C. J.
    Furuya, E. Y.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3601 - 3607
  • [9] Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China
    Cienfuegos-Gallet, Astrid, V
    Zhou, Ying
    Ai, Wenxiu
    Kreiswirth, Barry N.
    Yu, Fangyou
    Chen, Liang
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [10] Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
    Yi, Juan
    Liu, Chao
    Yang, Ping
    Wu, Zhen-chao
    Du, Chun-jing
    Shen, Ning
    FRONTIERS IN PHARMACOLOGY, 2023, 14